<DOC>
	<DOC>NCT02588820</DOC>
	<brief_summary>Pilot study to evaluate the impact of extremely early ART in the dynamics of viral reservoir, immune activation and inflammation in patients with HIV-1 infection of less than 20 days (Fiebig stages I-II) compared to patients with infection of 20-100 days (Fiebig stages III-V), to induce HIV functional cure.</brief_summary>
	<brief_title>Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Men who have sex with men Male's between18 and 65 years old Less than 100 days of infection Patient stage Fiebig I to V Negative or Incomplete western blot with negative p31 band P31 positive band in western blot Positive Delta32 CCR5 mutation, HLAB5701 or HLAB27 (Â´late' exclusion criteria) Active oncological disease Active hepatitis C virus infection</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>HIV</keyword>
</DOC>